Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2022;33(4):430-6
Article Links
The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic
Gökhan Sargın, Huseyin Baygin, Taskin Senturk
Authors Information

Department of Rheumatology, Aydın Adnan Menderes University, Aydın, Turkey

G Sargin

Keywords: rheumatoid arthritis, COVID-19, anxiety, depression, disease-modifying anti-rheumatic drugs
References
  1. Harapan H, Itoh N, Yufika A, Winardi W, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13:667-73.
  2. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020;324:782-93.
  3. Coughlin SS. Anxiety and Depression: Linkages with Viral Diseases. Public Health Rev 2012;34:7.
  4. Munjal S, Ferrando SJ, Freyberg Z. Neuropsychiatric Aspects of Infectious Diseases: An Update. Crit Care Clin 2017;33:681-712.
  5. Ko CH, Yen CF, Yen JY, Yang MJ. Psychosocial impact among the public of the severe acute respiratory syndrome epidemic in Taiwan. Psychiatry Clin Neurosci 2006;60:397-403. 
  6. Mak IW, Chu CM, Pan PC, Yiu MG, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry 2009;31:318-26.
  7. Cheng SK, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychol Med 2004;34:1187-95.
  8. Chua SE, Cheung V, McAlonan GM, Cheung C, Wong JW, Cheung EP, et al. Stress and psychological impact on SARS patients during the outbreak. Can J Psychiatry 2004;49:385-90.
  9. Park HY, Park WB, Lee SH, Kim JL, Lee JJ, Lee H, et al. Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health 2020;20:605.
  10. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health 2020;17:1729.
  11. Choi EPH, Hui BPH, Wan EYF. Depression and Anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health 2020;17:3740.
  12. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. COVID-19 BioB Outpatient Clinic Study group, Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun 2020;89:594-600.
  13. Hamasaki M, Origuchi T, Matsuura E. Factors associated with depressive symptoms in Japanese women with rheumatoid arthritis. Rheumatol Adv Pract 2022;6:rkac006.
  14. Liu T, Geng Y, Han Z, Wang G, Wang W, Ye Y, et al. Self-reported sleep disturbance is significantly associated with depression, anxiety, self-efficacy, and stigma in Chinese patients with rheumatoid arthritis. Psychol Health Med 2022:1-9. 
  15. Cai Q, Pesa J, Wang R, Fu AZ. Depression and food insecurity among patients with rheumatoid arthritis in NHANES. BMC Rheumatol 2022;6:6.
  16. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
  17. Beck AT, Steer RA, Garbin MG J. Psychometric properties of the Beck Depression Inventory Twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100. 
  18. Hisli N. Validity and reliability of Beck depression inventory for university students. Psikoloji Dergisi 1989;7:3-13.
  19. Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. 1990; San Antonio, TX: Psychological Corporation.
  20. Ulusoy M, Şahin N, Erkmen H. Turkish version of the beck anxiety inventory: psychometric properties. J Cognitive Psychotherapy: Int Quarterly 1998;12:28-35.
  21. Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav 2021;5:529-38.
  22. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Trauma Stress 2005;18: 39-42.
  23. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013;52:2136-48.
  24. Itaya T, Torii M, Hashimoto M, Tanigawa K, Urai Y, Kinoshita A, et al. Prevalence of anxiety and depression in patients with rheumatoid arthritis before and during the COVID-19 pandemic. Rheumatology (Oxford) 2021;60:2023-4.
  25. Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V. The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. Rheumatol Int 2020;40:1229-38.
  26. Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, et al. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis 2020;79:851-8.